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Background: Mean Platelet volume has been known to predict adverse cardiovascularevents in patients with ischemic heart disease. Since 
diastolic dysfunction is one of the earliest abnormalities with myocardial ischemia, we aimed to investigate the prognostic significance of MPV on 
admission in patients admitted for heart failure with preserved ejection fraction (HFPEF).
Methods: All consecutive patients admitted to Montefiore Medical Center with congestive symptoms, ejection fraction >50% and 
echocardiographic evidence of diastolic dysfunction were included. Adjusted Hazard Ratios (HR) for mortality were estimated using multiple Cox 
proportional hazard models. Proportional hazard assumptions were met.
Results: Overall, 14648 patients were included from Jan, 2000 - June Dec 2010. On average, they were 71 yrs old, 40% were males, 40% were 
Caucasians. We observed an approximately linear adjusted association between increasing MPV and increasing mortality (adjusted hazard ratio [HR] 
1.19 per 1 fl higher MPV, 95% CI: 1.15 - 1.22). We also noticed an increased risk of experiencing mortality among patients with abnormally elevated 
MPV [>10.5 fl (HR 0.1.43, 95% CI 1.37 - 1.49)] compared to those with a normal MPV (see table for more results). We observed no interaction by 
antiplatelet therapy, platelet count, and coexistant significant coronary disease.
Conclusions: Elevated mean platelet volume on admission was independently associated with worse long term mortality in patients with HFPEF. 
